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Asymptomatic excretion of group B streptococcus (GBS) in breast milk may be 29 
an under-recognised cause of neonatal and recurrent infection. We report the 30 
case of late-onset and recurrent infection in newborn twins resulting from 31 
ingestion of maternal breast milk infected with GBS. Genetic analysis of 32 
isolates is equally presented.  33 
 34 
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Group B streptococcus (GBS) is the most frequent cause of neonatal sepsis 41 
and meningitis. Most cases occur in the first week of life and are related to 42 
vaginal carriage in the mother (early-onset disease).  Conversely, late-onset 43 
disease (between 1 week and 3 months of age) is less common and is hand-44 
transmitted by nursery personnel or via other nosocomial or community 45 
pathways [6]. Late- onset and recurrent disease have also been reported with 46 
the ingestion of infected mother’s milk, with some cases confirmed using 47 
molecular techniques [2-4, 7, 9, 13].  We report in this article the case of late-48 
onset and recurrent infection in newborn twins resulting from ingestion of 49 
maternal breast milk infected with GBS. In this case genetic analysis 50 
demonstrated that all GBS isolates (maternal breast milk and vaginal isolates; 51 
twin CSF and blood isolates)  were identical, but additional genetic analysis 52 
also revealed that the GBS isolates were of a particularly virulent clone 53 
belonging to serotype III, as are 90% of the strains responsible for late- onset 54 
disease [3]. 55 
 56 
Case report 57 
 58 
Premature twins were delivered by spontaneous vaginal delivery at 31 weeks 59 
gestation, 48 hours following membrane rupture. The 26 year- old mother, 60 
gravida 1, para 2, received intrapartum antibiotic prophylaxis (single dose of 61 
penicillin G) due to positive vaginal GBS culture at 30 weeks gestation. Twin 62 
1, female, weighed 1600g with an Apgar score of 10/10 at 1 and 5 minutes. 63 
No respiratory failure was noted and early enteral feeding was started with raw 64 
breast milk at day 1. Total enteral alimentation with breast milk was obtained 65 
at day 6. Twin 2, male, weighed 1720g with an Apgar score of 4/9 at 1 and 5 66 
 4 
minutes. He was intubated shortly after birth due to respiratory failure and 67 
received one dose of surfactant. By the 3rd hour of life, he was extubated and 68 
nasal CPAP was initiated. Enteral alimentation with raw breast milk was 69 
introduced at day 4. Antibiotic therapy with cefotaxime and amoxicillin was 70 
prescribed for both infants due to incomplete prepartum antibiotic prophylaxis 71 
and stopped at day 2 due to negative C- reactive protein as well as negative 72 
gastric and blood cultures.  Cerebral ultrasound examination was normal for 73 
both infants at day 4. 74 
On day 13, Twin 2 developed cardio-respiratory instability and blood culture 75 
tested positive for group B streptococcus. Meningitis was suspected due to 76 
elevated CSF protein concentration. Until day 16 Twin 1 was asymptomatic 77 
with negative C- reactive protein control. On day 16, she developed 78 
respiratory distress and subsequent blood and cerebrospinal fluid cultures 79 
tested positive for GBS.  Antibiotic treatment with amoxicillin at 200mg/day 80 
was prescribed for 14 days, in association with an aminoglycoside during the 81 
first 48 hours of treatment. Control blood cultures were negative after day 1, 3 82 
and 5 of treatment. Cerebral ultrasound examination controls were normal for 83 
both infants. At day 41 of life Twin 1 developed septic syndrome with parotitis 84 
and was transferred to the NICU. Blood culture was positive for GBS. Cardiac 85 
ultrasound examination was normal. Antibiotic therapy with cefotaxime 86 
(200mg/kg/day) and tobramycin (5mg/kg/day) was initiated. At day 7 of 87 
infection tomodensitometry examination identified cerebral microabcess and 88 
modification of the antibiotherapy ensued, with the administration of 89 
ciprofloxacin (30 mg/kg/day) associated with cefotaxime (250 mg/kg/day) for 3 90 
weeks. Then oral amoxicillin was initiated for 3 additional weeks. Mastitis was 91 
diagnosed in the infants’ mother 24 hours following discovery of GBS infection 92 
in Twin 1 (day 42). Milk culture tested positive for GBS and the maternal 93 
infection was treated with amoxicillin for 10 days. Breastfeeding was 94 
 5 
suspended and a 10- day preventive oral amoxicillin treatment given to the 95 
non- infected twin (confirmed via negative blood and CSF cultures as well as 96 
negative CRP controls). Following this infection, the infants remained on 97 
pasteurized breast milk. Follow- up at one year showed no cerebral anomalies 98 
upon ultrasound examination in association with normal neurological 99 
examinations at 1 year of life. 100 
 101 
Analysis revealed all strains as belonging to serotype III. Epidemiological 102 
relationships between maternal and neonatal GBS isolates were investigated 103 
by pulsed-field gel electrophoresis (PFGE) of DNA restricted with SmaI [11]. 104 
Analysis was conducted on maternal vaginal and raw breast milk isolates (2 105 
isolates), a single Twin 2 blood culture isolate (1 isolate), and on Twin 1 CSF 106 
and first- and -second blood culture isolates (3 isolates). All six isolates 107 
displayed identical PFGE patterns, revealing their genetic relationship (figure 108 
1A).  109 
Characterization of isolate virulence was conducted by multiplex PCR 110 
according to primers and method previously described [11, 12]. First, 111 
amplification of the tRNA gene clusters at the 3’ end of rRNA operons 112 
produced a unique fragment of 1.2 Kb (figure 1B); second, hylB amplification 113 
produced a 0.3 Kb fragment, showing no IS1548 insertion within the gene 114 
(figure 1B). This pattern was correlated to the invasive phylogenetic division I 115 
defined by Musser et al. in multilocus enzyme electrophoresis (MLEE) 116 




Cases reporting neonatal late and recurrent group B streptococcal disease 121 
associated with raw maternal milk are rare, and few are the studies in which 122 
 6 
genetic evidence is proposed for this scenario [2, 7, 13]. In our case, not only 123 
was total DNA macrorestriction analysis conducted, showing indistinguishable 124 
patterns for the six isolates, but additional genetic analysis also revealed that 125 
the GBS isolates belonged to a particularly virulent clone shown to produce 126 
more extracellular neuraminidase [8]. These isolates, as 90% of the strains 127 
responsible for late onset disease [3], belonged to serotype III. 128 
 129 
If the physiopathology of early onset GBS disease is well-documented, little is 130 
known about late or recurrent GBS infections. This case offers a novel 131 
hypothesis explaining how GBS can cause neonatal infection from 7 days to 3 132 
months following delivery. 133 
In most of the rare cases described [7, 9], there were  no signs of maternal 134 
mastitis, indicating a silent maternal duct colonization. Moreover, National 135 
Committee of Hygiene guidelines do not systematically screen for GBS in the 136 
raw maternal milk supply [1]. These may be two reasons for the 137 
underestimation of maternal milk as a source of GBS infection. In the present 138 
case, genetic analysis affords evidence for maternal milk as the source of 139 
neonatal GBS infection. A circular process was hypothesized by Kotiw et al 140 
[7]. GBS initially colonizes the neonate's oropharynx mucosa from perinatal or 141 
other sources, infecting maternal ducts during breastfeeding. The organism 142 
multiplies in the milk ducts. As the microbial concentration increases in the 143 
milk, the infant is re-infected during breastfeeding. Mastitis may or may not be 144 
present [7]. However Olver et al described cases of GBS infection in preterm 145 
infants fed with maternal milk via nasogastric tube alone [9]. Prematurity is a 146 
recognized predisposing factor to GBS infection although breast milk 147 
transmission was also described in term infants [4]. 148 
In our unit, expressed mother’s milk is systematically pasteurized and frozen 149 
for conservation in our lactarium, and each specimen of milk is screened for 150 
 7 
bacteria before administration to preterm infants. However, preterm infants 151 
might also receive raw, freshly-expressed breast milk from their mothers 152 
present in the unit. When a preterm infant falls clinically ill while the mother is 153 
breastfeeding, the mother’s milk should be cultured to rule out or to document 154 
possible breast milk transmission. Mother’s milk feedings should be 155 
suspended while providing banked milk pending culture result. If breast milk is 156 
positive for GBS, adequate antibiotherapy should also be prescribed for the 157 
mother. Byrne et al reported that it is possible to give the mother the 158 
opportunity to continue breastfeeding as desired ; she can be encouraged to 159 
maintain her milk supply by pumping and discarding milk until appropriate 160 
treatment is completed and negative breast milk cultures are obtained [4]. 161 
 162 
Asymptomatic excretion of GBS in breast milk may be an under-recognised 163 
cause of neonatal and recurrent infection. Recommendations should be 164 
established to prevent these infections, notably in the case of multiple births: 165 
1/ treatment of both twins; 2 / recognition of the possibility of GBS breast milk 166 
infection in late onset or recurrent infection; 3/ suspension of breastfeeding 167 
upon suspicion of GBS breast milk infection in both of the children; 4/ search 168 
for GBS colonization in both mother and children. 169 
However, it should also be noted that use of human milk in the intensive care 170 
nursery decreases the incidence of nosocomial sepsis [5] and breastfeeding 171 
should still be considered as the most appropriate nutrition for babies and 172 
preterm infants [1]. 173 
 174 
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Figure 1 221 
A.  Pulsed-field gel electrophoresis (PFGE) of DNA restricted with SmaI of 222 
maternal and neonatal GBS isolates. All six isolates displayed identical PFGE 223 
patterns, showing their genetic relationship. Molecular weight (MW) ; maternal 224 
vaginal isolate (lane 1) ; Twin 1 CSF (lane 2) ; maternal raw breast milk isolate 225 
(lane 3) ; first (lane 4) and second (lane 5) Twin 1 blood culture isolates, and 226 
Twin 2 blood culture isolate (lane 6). 227 
B.  Ethidium bromide stain of 2% agarose gel showing multiplex PCR products 228 
for the GBS clinical isolates. Amplification of the tRNA gene clusters at the 3’ 229 
end of rRNA operons produced a unique fragment of 1.2 Kb ; amplification 230 
hylB gene produced a 0.3 Kb fragment, showing no IS1548 insertion within the 231 
gene. This pattern was correlated to the invasive phylogenetic division I 232 
defined by Musser et al. in multilocus enzyme electrophoresis (MLEE) 233 
analysis [8, 12]. MW, molecular weight ; lane 1, maternal vaginal isolate ; lane 234 
2, twin 1 CSF isolate ; lane 3, maternal raw breast milk isolate ; lanes 4 and 5, 235 
first and second twin 1 blood culture isolates. 236 
237 
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